A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
for
Chronic Lymphocytic Leukemia
Location: Boston MA, Quebec, Sherbrooke, New York NY, Montreal,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07277231
Phase3, Recruiting
Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers
Location: Oradell NJ, Springfield IL, O'Fallon IL, McAllen TX
Sponsor: Eluciderm Inc
Sex: All
Age: 18 - 70+
Code: NCT07396376
Phase1, Phase2, Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Stony Brook NY, Lake Success NY, Manhasset NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03739814
Phase2, Recruiting
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
for
Acute Lymphoblastic Leukemia
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 40+
Code: NCT07400029
Phase2, Recruiting
A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
for
Leukemia, Acute Myeloid Leukemia,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 25
Code: NCT06810583
Phase1, Recruiting
Interested in new lymphoma trials?
Get alerts for new trials in your area by subscribing now
Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
for
Acute Myeloid Leukemia, Acute Lymphoid Leukemia,
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 18 - 70
Code: NCT06551584
Phase1, Recruiting
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT06738368
Phase2, Recruiting
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression